Zydus Pharmaceuticals Recalls Chlorpromazine Tablets Over Contamination
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects a specific lot due to contamination with N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Product Details
Chlorpromazine Hydrochloride Tablets, USP, 10 mg, 100-count bottle. Manufactured by Zydus Lifesciences Ltd., Baddi, India, and distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ. NDC: 70710-1129-1.
The Hazard
The recall results from CGMP deviations, specifically the presence of N-Nitroso Desmethyl Chlorpromazine above the acceptable intake limit. This contamination poses serious health risks.
What to Do
Consumers should stop using Chlorpromazine Hydrochloride Tablets immediately. Contact Zydus Pharmaceuticals or a healthcare provider for further guidance.
Contact Information
For assistance, call Zydus Pharmaceuticals (USA) Inc. at 1-800-XXX-XXXX. Visit the FDA recall page for more information.